HomeCompareTEPLX vs JNJ

TEPLX vs JNJ: Dividend Comparison 2026

TEPLX yields 15.24% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TEPLX wins by $34.3K in total portfolio value
10 years
TEPLX
TEPLX
● Live price
15.24%
Share price
$26.67
Annual div
$4.06
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$54.3K
Annual income
$3,901.82
Full TEPLX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — TEPLX vs JNJ

📍 TEPLX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTEPLXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TEPLX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TEPLX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TEPLX
Annual income on $10K today (after 15% tax)
$1,295.11/yr
After 10yr DRIP, annual income (after tax)
$3,316.55/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, TEPLX beats the other by $2,612.93/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TEPLX + JNJ for your $10,000?

TEPLX: 50%JNJ: 50%
100% JNJ50/50100% TEPLX
Portfolio after 10yr
$37.1K
Annual income
$2,364.80/yr
Blended yield
6.37%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TEPLX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TEPLX buys
0
JNJ buys
0
No recent congressional trades found for TEPLX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTEPLXJNJ
Forward yield15.24%3.36%
Annual dividend / share$4.06$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$54.3K$20.0K
Annual income after 10y$3,901.82$827.78
Total dividends collected$26.5K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TEPLX vs JNJ ($10,000, DRIP)

YearTEPLX PortfolioTEPLX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,224$1,523.66$10,676$355.77+$1.5KTEPLX
2$14,820$1,740.63$11,407$389.39+$3.4KTEPLX
3$17,830$1,972.27$12,198$426.53+$5.6KTEPLX
4$21,295$2,217.58$13,056$467.62+$8.2KTEPLX
5$25,261$2,475.34$13,987$513.12+$11.3KTEPLX
6$29,774$2,744.25$14,998$563.56+$14.8KTEPLX
7$34,881$3,022.87$16,098$619.52+$18.8KTEPLX
8$40,632$3,309.70$17,295$681.69+$23.3KTEPLX
9$47,080$3,603.20$18,599$750.82+$28.5KTEPLX
10$54,277$3,901.82$20,022$827.78+$34.3KTEPLX

TEPLX vs JNJ: Complete Analysis 2026

TEPLXStock

The fund invests predominantly in the equity securities of companies located anywhere in the world, including developing markets. The equity securities in which the fund primarily invests are common stock. The fund may invest in companies of any size, including small and medium capitalization companies. Although the adviser seeks investments across a number of regions, countries and sectors, from time to time, based on economic conditions, the adviser may have significant positions in particular regions, countries or sectors.

Full TEPLX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this TEPLX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TEPLX vs SCHDTEPLX vs JEPITEPLX vs OTEPLX vs KOTEPLX vs MAINTEPLX vs ABBVTEPLX vs MRKTEPLX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.